Drosophila modeling of heritable neurodevelopmental disorders

Current Opinion in Neurobiology

Volumn 21, Issue 6, 2011, Pages 834-841

  Gatto, Cheryl L ^a   Broadie, Kendal ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; METHYL CPG BINDING PROTEIN 2; NEUROFIBROMIN; RAS PROTEIN; SPASTIN; UBIQUITIN LIGASE 3A; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

BEHAVIOR DISORDER; CALCIUM SIGNALING; CIRCADIAN RHYTHM; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DROSOPHILA; FRAGILE X MENTAL RETARDATION 1 GENE; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; HAPPY PUPPET SYNDROME; HERITABILITY; HUMAN; LEARNING; LOSS OF FUNCTION MUTATION; MEMORY; NEUROFIBROMATOSIS; NEUROMUSCULAR SYNAPSE; NF1 GENE; NONHUMAN; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; SLEEP DISORDER; SUPPRESSOR GENE; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT; UBIQUITINATION;

ANIMALS; CHILD; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS;

EID: 84855512490     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2011.04.009     Document Type: Review

References (76)

1. Gatto C.L., Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Syn Neurosci 2010, 2. 10.3389/fnsyn.2010.00004.
2. Reiter L.T., Potocki L., Chien S., Gribskov M., Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 2001, 11:1114-1125.
3. Williams C.A., Driscoll D.J., Dagli A.I. Clinical and genetic aspects of Angelman syndrome. Genet Med 2010, 12:385-395.
4. Yamasaki K., Joh K., Ohta T., Masuzaki H., Ishimaru T., Mukai T., Niikawa N., Ogawa M., Wagstaff J., Kishino T. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet 2003, 12:837-847.
5. Chamberlain S.J., Lalande M. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol Dis 2010, 39:13-20.
6. Dan B. Angelman syndrome: current understanding and research prospects. Epilepsia 2009, 50:2331-2339.
7. Reiter L.T., Seagroves T.N., Bowers M., Bier E. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum Mol Genet 2006, 15:2825-2835.
8. Wu Y., Bolduc F.V., Bell K., Tully T., Fang Y., Sehgal A., Fischer J.A. A Drosophila model for Angelman syndrome. Proc Natl Acad Sci USA 2008, 105:12399-12404.
9. Lu Y., Wang F., Li Y., Ferris J., Lee J.A., Gao F.B. The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches. Hum Mol Genet 2009, 18:454-462.
10. Ferdousy F., Bodeen W., Summers K., Doherty O., Wright O., Elsisi N., Hilliard G., O'Donnell J.M., Reiter L.T. Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol Dis 2010, 41:669-677.
11. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., Alvarez Retuerto A.I., Imielinski M., Hadley D., Bradfield J.P., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009, 5:e1000536.
12. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
13. Harbord M. Levodopa responsive Parkinsonism in adults with Angelman Syndrome. J Clin Neurosci 2001, 8:421-422.
14. Mulherkar S.A., Jana N.R. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis 2010, 40:586-592.
15. Zhang Y.Q., Friedman D.B., Wang Z., Woodruff E., Pan L., O'Donnell J., Broadie K. Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol Cell Proteomics 2005, 4:278-290.
16. Gonzales M.L., LaSalle J.M. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 2010, 12:127-134.
17. Na E.S., Monteggia L.M. The role of MeCP2 in CNS development and function. Horm Behav 2010, 59:364-368.
18. Matsuishi T., Yamashita Y., Takahashi T., Nagamitsu S. Rett syndrome: the state of clinical and basic research, and future perspectives. Brain Dev 2011, 10.1016/j.braindev.2010.12.007.
19. Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M., Schaaf C.P., Richman R., Fang P., Glaze D.G., Lupski J.R., et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009, 66:771-782.
20. Ramocki M.B., Tavyev Y.J., Peters S.U. The MECP2 duplication syndrome. Am J Med Genet A 2010, 152A:1079-1088.
21. Ariani F., Hayek G., Rondinella D., Artuso R., Mencarelli M.A., Spanhol-Rosseto A., Pollazzon M., Buoni S., Spiga O., Ricciardi S., et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008, 83:89-93.
22. Mari F., Azimonti S., Bertani I., Bolognese F., Colombo E., Caselli R., Scala E., Longo I., Grosso S., Pescucci C., et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005, 14:1935-1946.
23. Sprovieri T., Conforti F.L., Fiumara A., Mazzei R., Ungaro C., Citrigno L., Muglia M., Arena A., Quattrone A. A novel mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene associated with a severe Rett phenotype. Am J Med Genet A 2009, 149A:722-725.
24. Jacob F.D., Ramaswamy V., Andersen J., Bolduc F.V. Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet 2009, 17:1577-1581.
25. Mencarelli M.A., Spanhol-Rosseto A., Artuso R., Rondinella D., De Filippis R., Bahi-Buisson N., Nectoux J., Rubinsztajn R., Bienvenu T., Moncla A., et al. Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 2010, 47:49-53.
26. Hendrich B., Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 2003, 19:269-277.
27. Meins M., Lehmann J., Gerresheim F., Herchenbach J., Hagedorn M., Hameister K., Epplen J.T. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet 2005, 42:e12.
28. Van Esch H., Bauters M., Ignatius J., Jansen M., Raynaud M., Hollanders K., Lugtenberg D., Bienvenu T., Jensen L.R., Gecz J., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005, 77:442-453.
29. del Gaudio D., Fang P., Scaglia F., Ward P.A., Craigen W.J., Glaze D.G., Neul J.L., Patel A., Lee J.A., Irons M., et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 2006, 8:784-792.
30. Cukier H.N., Perez A.M., Collins A.L., Zhou Z., Zoghbi H.Y., Botas J. Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet 2008, 4:e1000179.
31. Payne J.M., Moharir M.D., Webster R., North K.N. Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 2010, 81:304-309.
32. Shilyansky C., Lee Y.S., Silva A.J. Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu Rev Neurosci 2010, 33:221-243.
33. Ferner R.E. The neurofibromatoses. Pract Neurol 2010, 10:82-93.
34. Johannessen C.M., Reczek E.E., James M.F., Brems H., Legius E., Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci USA 2005, 102:8573-8578.
35. Cui Y., Costa R.M., Murphy G.G., Elgersma Y., Zhu Y., Gutmann D.H., Parada L.F., Mody I., Silva A.J. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008, 135:549-560.
36. The I., Hannigan G.E., Cowley G.S., Reginald S., Zhong Y., Gusella J.F., Hariharan I.K., Bernards A. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 1997, 276:791-794.
37. Guo H.F., The I., Hannan F., Bernards A., Zhong Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997, 276:795-798.
38. Guo H.F., Tong J., Hannan F., Luo L., Zhong Y. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 2000, 403:895-898.
39. Tully T., Quinn W.G. Classical conditioning and retention in normal and mutant Drosophila melanogaster. J Comp Physiol [A] 1985, 157:263-277.
40. Connolly J.B., Tully T. Behaviour, learning, and memory. Drosophila, A Practical Approach 1998, 265-318. Oxford University Press. edn 2. D.B. Roberts (Ed.).
41. Margulies C., Tully T., Dubnau J. Deconstructing memory in Drosophila. Curr Biol 2005, 15:R700-R713.
42. Williams J.A., Su H.S., Bernards A., Field J., Sehgal A. A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science 2001, 293:2251-2256.
43. Ho I.S., Hannan F., Guo H.F., Hakker I., Zhong Y. Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. J Neurosci 2007, 27:6852-6857.
44. Buchanan M.E., Davis R.L. A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory. J Neurosci 2010, 30:10135-10143.
45. Hagerman P.J. The fragile X prevalence paradox. J Med Genet 2008, 45:498-499.
46. Harris S.W., Hessl D., Goodlin-Jones B., Ferranti J., Bacalman S., Barbato I., Tassone F., Hagerman P.J., Herman H., Hagerman R.J. Autism profiles of males with fragile X syndrome. Am J Ment Retard 2008, 113:427-438.
47. Hagerman R. Commonalities in the neurobiology between autism and fragile X. J Intellect Disabil Res 2008, 52:817.
48. Bakker C., Verheij C., Willemsen R., van der Helm R. Fmr1 knockout mice: a model to study fragile X mental retardation, The Dutch-Belgian Fragile X Consortium. Cell 1994, 78:23-33.
49. Zhang Y.Q., Bailey A.M., Matthies H.J., Renden R.B., Smith M.A., Speese S.D., Rubin G.M., Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001, 107:591-603.
50. Gatto C.L., Broadie K. The fragile x mental retardation protein in circadian rhythmicity and memory consolidation. Mol Neurobiol 2009, 39:107-129.
51. Tessier C.R., Broadie K. Activity-dependent modulation of neural circuit synaptic connectivity. Front Mol Neurosci 2009, 2:8.
52. Bhogal B., Jongens T.A. Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention. Dis Model Mech 2010, 3:693-700.
53. Coffee R.L., Tessier C.R., Woodruff E.A., Broadie K. Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P. Dis Model Mech 2010, 3:471-485.
54. Epstein A.M., Bauer C.R., Ho A., Bosco G., Zarnescu D.C. Drosophila Fragile X protein controls cellular proliferation by regulating cbl levels in the ovary. Dev Biol 2009, 330:83-92.
55. Yang Y., Xu S., Xia L., Wang J., Wen S., Jin P., Chen D. The bantam microRNA is associated with drosophila fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet 2009, 5:e1000444.
56. Monzo K., Dowd S.R., Minden J.S., Sisson J.C. Proteomic analysis reveals CCT is a target of Fragile X mental retardation protein regulation in Drosophila. Dev Biol 2010, 340:408-418.
57. Papoulas O., Monzo K.F., Cantin G.T., Ruse C., Yates J.R., Ryu Y.H., Sisson J.C. dFMRP and Caprin, translational regulators of synaptic plasticity, control the cell cycle at the Drosophila mid-blastula transition. Development 2010, 137:4201-4209.
58. Pepper A.S., Beerman R.W., Bhogal B., Jongens T.A. Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects. PLoS ONE 2009, 4:e7618.
59. Callan M.A., Cabernard C., Heck J., Luois S., Doe C.Q., Zarnescu D.C. Fragile X protein controls neural stem cell proliferation in the Drosophila brain. Hum Mol Genet 2010, 19:3068-3079.
60. Cziko A.M., McCann C.T., Howlett I.C., Barbee S.A., Duncan R.P., Luedemann R., Zarnescu D., Zinsmaier K.E., Parker R.R., Ramaswami M. Genetic modifiers of dFMR1 encode RNA granule components in Drosophila. Genetics 2009, 182:1051-1060.
61. Bianco A., Dienstbier M., Salter H.K., Gatto G., Bullock S.L. Bicaudal-D regulates fragile X mental retardation protein levels, motility, and function during neuronal morphogenesis. Curr Biol 2010, 20:1487-1492.
62. Trotta N., Orso G., Rossetto M.G., Daga A., Broadie K. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 2004, 14:1135-1147.
63. Yao A., Jin S., Li X., Liu Z., Ma X., Tang J., Zhang Y.Q. Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. Hum Mol Genet 2010, 20:51-63.
64. Gatto C.L., Broadie K. Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture. Front Neural Circuits 2009, 3:8.
65. Dockendorff T.C., Su H.S., McBride S.M., Yang Z., Choi C.H., Siwicki K.K., Sehgal A., Jongens T.A. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 2002, 34:973-984.
66. Reeve S.P., Bassetto L., Genova G.K., Kleyner Y., Leyssen M., Jackson F.R., Hassan B.A. The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr Biol 2005, 15:1156-1163.
67. Reeve S.P., Lin X., Sahin B.H., Jiang F., Yao A., Liu Z., Zhi H., Broadie K., Li W., Giangrande A., et al. Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP. J Neurosci 2008, 28:3221-3226.
68. Bushey D., Tononi G., Cirelli C. The Drosophila fragile X mental retardation gene regulates sleep need. J Neurosci 2009, 29:1948-1961.
69. Tessier C.R., Broadie K. The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons. Neurobiol Dis 2010, 41:147-159.
70. Bolduc F.V., Bell K., Cox H., Broadie K.S., Tully T. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci 2008, 11:1143-1145.
71. McBride S.M., Choi C.H., Wang Y., Liebelt D., Braunstein E., Ferreiro D., Sehgal A., Siwicki K.K., Dockendorff T.C., Nguyen H.T., et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 2005, 45:753-764.
72. Bolduc F.V., Bell K., Rosenfelt C., Cox H., Tully T. Fragile x mental retardation 1 and filamin a interact genetically in Drosophila long-term memory. Front Neural Circuits 2010, 3:22.
73. Banerjee P., Schoenfeld B.P., Bell A.J., Choi C.H., Bradley M.P., Hinchey P., Kollaros M., Park J.H., McBride S.M., Dockendorff T.C. Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein. J Neurosci 2010, 30:6782-6792.
74. Choi C.H., McBride S.M., Schoenfeld B.P., Liebelt D.A., Ferreiro D., Ferrick N.J., Hinchey P., Kollaros M., Rudominer R.L., Terlizzi A.M., et al. Age-dependent cognitive impairment in a Drosophila fragile X model and its pharmacological rescue. Biogerontology 2010, 11:347-362.
75. Bolduc F.V., Valente D., Nguyen A.T., Mitra P.P., Tully T. An assay for social interaction in Drosophila fragile X mutants. Fly (Austin) 2010, 4.
76. Kelley D.J., Bhattacharyya A., Lahvis G.P., Yin J.C., Malter J., Davidson R.J. The cyclic AMP phenotype of fragile X and autism. Neurosci Biobehav Rev 2008, 32:1533-1543.